We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Vaccines have helped reduce the instance of infectious diseases around the globe, nearly eradicating past plagues, such as smallpox and polio. A very effective method of delivery is intradermal (ID) injection – now made easier with two novel products on the market.
NanoPass MicronJet600™ West's Intradermal Adapter
Intramuscular (IM) and subcutaneous (SC) injections are the most common methods of vaccine delivery. However, the ideal location for injection is the skin. It contains a high concentration of antigen presenting cells that perform an essential role in processing incoming antigens –resulting in powerful immune system responses. Thus, 1ID injection (i.e., delivery to the epidermis or dermis) may result in superior immune responses.
In addition to the superior immune response, ID delivery offers a variety of benefits to pharmaceutical manufacturers, including dose sparing, increased availability of limited or expensive antigens, and reduced cost per dose. Typically, ID injection employs the Mantoux technique, which requires special training, and may not effectively target the skin – resulting either in delivery to the SC tissue (too deep), or leakage (too shallow). These issues of training and inconsistency have deterred many practitioners from using ID injection. To address this problem, West now offers two devices to help deliver a reliable and consistent ID injection each time.
The West ID Adapter device is a snap-on guide for a syringe – ideal for mass vaccinations in developing regions. The MicronJet600™ adapter is a microneedle solution – for a variety of immunotherapies and vaccinations (offered thru our collaboration with NanoPass Technologies, Ltd.) Both devices are suitable for a broad range of ages (2The MicronJet600 was evaluated in various age groups from infants to the elderly)
Visit our website or contact West today to learn more about how we can help you overcome intradermal delivery challenges.
MicronJet600™ is a trademark of NanoPass Technologies, Ltd.
Today’s business environment demands a seamless and continual transition of digital experience to conduct business and engage various stakeholders in the same way we conduct the rest of our lives outside work. The experience expectation is consistent across devices of choice from phones to tablets to laptops. That’s why West partners with the world’s top pharmaceutical, biotech, device and diagnostic companies to embrace technology that supports the patients they serve with online resources and tools to better manage their health. In turn, we’re looking to support our customers with digital tools to help speed the research and development process of bringing life-saving medicines to patients that need them.
West is honored to be a recipient of the Philadelphia Business Journal’s 2019 Faces of Philanthropy Award. The honor was presented to West at the Business Journal’s Faces of Philanthropy Awards Breakfast on April 11, 2019 in Philadelphia, PA.
Elemental impurities, such as arsenic, cadmium, lead and mercury are ubiquitous in nature. They are also toxic to humans and animals at certain levels. Because these elements are often part of mined minerals used in the manufacture of drug products and/or drug containment systems, they can have an impact on the quality of a drug. <br />
Rubber components are essential for the safe containment and delivery of parenteral drug products. Many rubber formulations used in the pharmaceutical industry are based on halobutyl rubbers. Halobutyl rubbers, typically bromobutyl or chlorobutyl, are made by the halogenation of butyl rubber, which is a copolymer of isobutylene and isoprene (to a smaller extent). Key features of halobutyl rubbers that make them suitable for the pharmaceutical industry are that they typically have lower levels of extractables compared to other rubbers, and they have excellent resistance to permeation by water and oxygen.
For many pharmaceutical manufacturers, commercial filling lines are simply a part of the manufacturing process. But when a drug is still in development or requires prescreen stability testing for new primary container selection , small-quantity filling can be difficult. To send such quantities to a contract manufacturer or commercial lines, such as isolator or RABs, can be expensive and time consuming.
English
Chinese
